<DOC>
	<DOCNO>NCT00491296</DOCNO>
	<brief_summary>PURPOSE : We determine whether Synergo therapy- intravesical chemotherapy instillation combine hyperthermia instillation associate elevated prostate specific antigen ( PSA ) . MATERIALS AND METHODS : We treat 25 consecutive patient bladder cancer 6-week course Synergo therapy , follow cystoscopy 6 week . Blood sample PSA determination obtain synergo therapy application cystoscopy patient also serve control . Evaluating change PSA level patient undergoing treatment Synergo deliver local hyperthermia combine intravesical instillation Mitomycin C adjuvant treatment pt . recurrent tu bladder post TURT BCGtreatment .</brief_summary>
	<brief_title>Changes Prostate Specific Antigen Levels During Synergo Therapy-Intravesical Chemotherapy Instillations Combined With Hyperthermia</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>Recurrent transitional cell carcinoma urinary bladder post endoscopic resection PSA Prior synergo therapy application &lt; 10 Normal rectal examination Patients willing sign inform consent accord History prostate cancer Previous history TCC stage T2 higher Invasive tu bladder Prior pelvic radiotherapy systemic chemotherapy Active prostatitis Active tuberculosis</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>S/P Transuretral resection bladder tumor</keyword>
	<keyword>Recurrent tumor BCG Treatment</keyword>
</DOC>